Singapore markets closed

NeuroSense Therapeutics Ltd. (NRSN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0250+0.1398 (+15.79%)
At close: 03:59PM EST
1.0500 +0.02 (+2.44%)
Pre-market: 05:29AM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
7,218
6,416
3,082
2,495
898
Selling general and administrative
6,711
7,136
2,505
393
337
Total operating expenses
13,929
13,552
5,587
2,888
1,235
Operating income or loss
-13,929
-13,552
-5,587
-2,888
-1,235
Interest expense
302
15
-
1
5
Total other income/expenses net
609
1,143
2,700
-
18
Income before tax
-13,514
-12,340
-4,041
-2,828
-1,222
Income from continuing operations
-13,514
-12,340
-4,041
-2,828
-1,222
Net income
-13,514
-12,340
-4,041
-2,828
-1,222
Net income available to common shareholders
-13,514
-12,340
-4,041
-2,828
-1,222
Basic EPS
-1.29
-1.07
-0.65
-0.26
-0.11
Diluted EPS
-1.29
-1.07
-0.65
-0.26
-0.11
Basic average shares
12,669
11,505
6,243
10,944
10,944
Diluted average shares
12,669
11,505
6,243
10,944
10,944